• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Anixa Biosciences, Inc. - Common Stock (NQ:ANIX)

    2.860 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Mar 12, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 2.860
    Bid (Size) 2.780 (600)
    Ask (Size) 3.090 (100)
    Prev. Close 2.860
    Today's Range 2.860 - 2.860
    52wk Range 2.331 - 5.457
    Shares Outstanding 33,527,858
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BioMedNewsBreaks — Anixa Biosciences, Inc. (NASDAQ: ANIX) CAR-T Co-Inventor To Keynote SCTR 2026 Retreat
    Via Investor Brand Network
    Water Tower Research Publishes Initiation of Coverage Report on Anixa Biosciences, Inc., “Anixa’s T-Cell Innovations Show Breakthrough Potential in Solid Tumors”
    January 21, 2026, ST. PETERSBURG, FL – Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Anixa Biosciences, Inc. (NASDAQ: ANIX) titled, “Anixa’s T-Cell... 
    Via TheNewswire.com

    Performance

    YTD
    -9.5%
    -9.5%
    1 Month
    -3.7%
    -3.7%
    3 Month
    -40.4%
    -40.4%
    6 Month
    -3.1%
    -3.1%
    1 Year
    +6.7%
    +6.7%

    More News

    Read More
    News headline image
    3 Under-the-Radar Biotechs Under $5 That Could Soar 200% ↗
    Via MarketBeat
    News headline image
    EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent ↗
    Via Benzinga
    Topics Intellectual Property
    News headline image
    Recap: Anixa Biosciences Q1 Earnings ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    EXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI Solutions To Develop AI-Guided Personalized Cancer Vaccines ↗
    Via Benzinga
    News headline image
    EXCLUSIVE: Anixa Biosciences Poised To Receive US Patent For Ovarian Cancer Vaccine ↗
    Via Benzinga
    Topics Intellectual Property
    News headline image
    This ACNB Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday ↗
    Via Benzinga
    News headline image
    iAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024
    Via ACCESSWIRE
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Anixa Biosciences And 3 Other Stocks Under $5 Insiders Are Buying ↗
    Via Benzinga
    News headline image
    EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy ↗
    Via Benzinga
    News headline image
    EXCLUSIVE: Anixa Biosciences Finds Stock Undervalued, Launches $5M Stock Buyback Program ↗
    Via Benzinga
    News headline image
    ANIX Stock Earnings: Anixa Biosciences Beats EPS for Q2 2024 ↗
    Via InvestorPlace
    News headline image
    7 Penny Biotech Stocks to Triple Your Investment ↗
    Via InvestorPlace
    Anixa Biosciences, Inc. (NASDAQ: ANIX) Featured in Coverage of the EF Hutton Annual Global Conference
    Via Investor Brand Network
    News headline image
    Sidoti Events, LLC's Virtual May Micro-Cap Conference
    Via ACCESSWIRE
    Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
    Via AB Newswire
    News headline image
    Sidoti Events, LLC's Virtual January Micro-Cap Conference
    Via ACCESSWIRE
    News headline image
    Anixa Biosciences, A New Type Of Biotech Company: Could It Disrupt The Cancer Landscape? ↗
    Via Benzinga
    News headline image
    3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023 ↗
    Via InvestorPlace
    News headline image
    Anixa Biosciences Reveals Updated Data From Breast Cancer Vaccine Trial, Says 'Exceeded Expectations' ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    The 3 Most Undervalued Cheap Stocks to Buy in September 2023 ↗
    Via InvestorPlace

    Frequently Asked Questions

    Is Anixa Biosciences, Inc. - Common Stock publicly traded?
    Yes, Anixa Biosciences, Inc. - Common Stock is publicly traded.
    What exchange does Anixa Biosciences, Inc. - Common Stock trade on?
    Anixa Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Anixa Biosciences, Inc. - Common Stock?
    The ticker symbol for Anixa Biosciences, Inc. - Common Stock is ANIX on the Nasdaq Stock Market
    What is the current price of Anixa Biosciences, Inc. - Common Stock?
    The current price of Anixa Biosciences, Inc. - Common Stock is 2.860
    When was Anixa Biosciences, Inc. - Common Stock last traded?
    The last trade of Anixa Biosciences, Inc. - Common Stock was at 03/12/26 04:00 PM ET
    What is the market capitalization of Anixa Biosciences, Inc. - Common Stock?
    The market capitalization of Anixa Biosciences, Inc. - Common Stock is 95.89M
    How many shares of Anixa Biosciences, Inc. - Common Stock are outstanding?
    Anixa Biosciences, Inc. - Common Stock has 96M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.